A bone marrow or stem cell transplant may be beneficial for people with intermediate- to high-risk acute myeloid leukemia (AML) who are in remission and can tolerate an intensive treatment plan. Acute ...

总的来说，2025 年 ELN-DAVID 共识文件为 AML MRD 评估提供了全面的标准化框架。新共识引入了「低水平阳性（MRD-LL）」 及「最佳、警示、高风险」的定性反应分类，并细化了 MFC 和分子技术的检测阈值。此外，共识也明确了 ...

Acute myeloid leukemia (AML) is a type of blood and bone marrow cancer. AML can affect people of any age, but it is most common in adults. AML occurs when bone marrow produces abnormal blood cells, ...

DNA methylation profiles in whole blood samples from 77 patients with CN-AML in The Cancer Genome Atlas (LAML cohort) were analyzed. Individual 5’-cytosine-phosphate-guanine-3’ (CpG) sites were ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Bone marrow transplants can be lifesaving for patients with acute ...

新一代口服强效高选择性BCL-2抑制剂Mesutoclax的出现，为老年AML患者带来了突破性希望。在临床研究中，Mesutoclax联合阿扎胞苷治疗AML展现出抗肿瘤活性：新诊断AML患者的复合CR率达92%，uMRD率（微小残留病阴性率）为82.

Relapsed acute myeloid leukemia (AML) is when cancer returns after a period of remission. Refractory AML means cancer has not responded to multiple rounds of treatment. Both can affect your treatment ...